Publication: Genome-wide association study of platelet aggregation in African Americans
Issued Date
2015-05-30
Resource Type
ISSN
14712156
Other identifier(s)
2-s2.0-84930662804
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Genetics. Vol.16, No.1 (2015)
Suggested Citation
Rehan Qayyum, Lewis C. Becker, Diane M. Becker, Nauder Faraday, Lisa R. Yanek, Suzanne M. Leal, Chad Shaw, Rasika Mathias, Bhoom Suktitipat, Paul F. Bray Genome-wide association study of platelet aggregation in African Americans. BMC Genetics. Vol.16, No.1 (2015). doi:10.1186/s12863-015-0217-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35452
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Genome-wide association study of platelet aggregation in African Americans
Abstract
© Qayyum et al.; licensee BioMed Central. Background: We have previously shown that platelet aggregation has higher heritability in African Americans than European Americans. However, a genome-wide association study (GWAS) of platelet aggregation in African Americans has not been reported. We measured platelet aggregation in response to arachidonic acid, ADP, collagen, or epinephrine by optical aggregometry. The discovery cohort was 825 African Americans from the GeneSTAR study. Two replication cohorts were used: 119 African Americans from the Platelet Genes and Physiology Study and 1221 European Americans from GeneSTAR. Genotyping was conducted with Illumina 1 M arrays. For each cohort, age- and sex-adjusted linear mixed models were used to test for association between each SNP and each phenotype under an additive model. Results: Six SNPs were significantly associated with platelet aggregation (P < 5×10<sup>-8</sup>) in the discovery sample. Of these, three SNPs in three different loci were confirmed: 1) rs12041331, in PEAR1 (platelet endothelial aggregation receptor 1), replicated in both African and European Americans for collagen- and epinephrine-induced aggregation, and in European Americans for ADP-induced aggregation; 2) rs11202221, in BMPR1A (bone morphogenetic protein receptor type1A), replicated in African Americans for ADP-induced aggregation; and 3) rs6566765 replicated in European Americans for ADP-induced aggregation. The rs11202221 and rs6566765 associations with agonist-induced platelet aggregation are novel. Conclusions: In this first GWAS of agonist-induced platelet aggregation in African Americans, we discovered and replicated, novel associations of two variants with ADP-induced aggregation, and confirmed the association of a PEAR1 variant with multi-agonist-induced aggregation. Further study of these genes may provide novel insights into platelet biology.